Success Metrics

Clinical Success Rate

66.7%

Based on 4 completed trials

Completion Rate

67%(4/6)

Active Trials

1(13%)

Results Posted

0%(0 trials)

Terminated

2(25%)

Phase Distribution

Ph phase_3

25%

Ph early_phase_1

13%

Ph not_applicable

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Early Phase 1First-in-human

1(20.0%)

Phase 3Large-scale testing

2(40.0%)

N/ANon-phased studies

2(40.0%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

66.7%

4 of 6 finished

Non-Completion Rate

33.3%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Completed(4)

Terminated(2)

Other(1)

Detailed Status

Completed4

Terminated2

unknown1

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

66.7%

Most Advanced

Phase 3

Trials by Phase

Early Phase 11 (20.0%)

Phase 32 (40.0%)

N/A2 (40.0%)

Trials by Status

unknown113%

completed450%

recruiting113%

terminated225%

Recent Activity

1 active trials

Showing 5 of 8

recruiting

The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Paraganglioma (PPGLs)

NCT06440122

terminatedearly_phase_1

Biodistribution of 11C-PIB PET in Alzheimer's Disease, Frontotemporal Dementia, and Cognitively Normal Elderly

NCT00811122

completednot_applicable

Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in the Diagnosis of Indeterminate Adrenal Tumors on Conventional Imaging: A French Prospective Multicentric Study

NCT01284829

unknownphase_3

Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

NCT00433433

completed

Trial on Vascular Inflammation in Atopic Dermatitis

NCT02926807

View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials

NCT06440122

The Incidence and Outcomes of Metabolically Active Brown Adipose Tissue (aBAT) in Patients With Pheochromocytoma or Paraganglioma (PPGLs)

Recruiting

NCT00811122Early Phase 1

Biodistribution of 11C-PIB PET in Alzheimer's Disease, Frontotemporal Dementia, and Cognitively Normal Elderly

Terminated

NCT01284829Not Applicable

Performance of 18F-Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) in the Diagnosis of Indeterminate Adrenal Tumors on Conventional Imaging: A French Prospective Multicentric Study

Completed

NCT00433433Phase 3

Fludeoxyglucose F 18 PET Scan-Guided Therapy or Standard Therapy in Treating Patients With Previously Untreated Stage I or Stage II Hodgkin's Lymphoma

Unknown

NCT02926807

Trial on Vascular Inflammation in Atopic Dermatitis

Completed

NCT00537797Not Applicable

Accuracy of FDG-PET Scanning to Diagnose Malignant Thyroid Nodules

Completed

NCT00775957

Assessment of Hematopoietic Recovery Following Chemotherapy for Non-Hodgkin's Lymphoma

Terminated

NCT00119899Phase 3

Utility of FDG-PET Scan on the Selection of Patients for Resection of Hepatic Colorectal Metastases